U.S. CDC Advisors To Review Moderna And J&J COVID-19 Booster Injections This Month
October 8 (Reuters) – Independent advisers from the U.S. Centers for Disease Control and Prevention will meet later this month to make recommendations on booster doses for Moderna Inc’s COVID-19 vaccines (MRNA.O) and Johnson & Johnson (JNJ.N), the agency said Friday.
The meetings, October 20 and 21, are scheduled for a week after U.S. Food and Drug Administration advisers ruled on the need for booster doses of both vaccines.
The CDC panel, called the Immunization Practices Advisory Committee, will also discuss COVID-19 vaccines for children on November 2-3, a spokesperson for the agency said.
Pediatric meetings are also scheduled a week after FDA advisers reviewed the need for Pfizer Inc’s COVID-19 vaccine (PFE.N) in children aged five to 11.
Pfizer said Thursday that the company and its partner BioNTech SE have asked U.S. regulators to allow emergency use of their COVID-19 vaccine for children aged 5 to 11. read more
Report by Manas Mishra and Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta and Shinjini Ganguli
Our standards: Thomson Reuters Trust Principles.